Japan MHLW Requests Revisions To Nobel And MSD Product Warnings
This article was originally published in PharmAsia News
Executive Summary
PFSB Japan’s Safety Division has instructed Nobel and Merck to revise the precautions for use regarding the dysmenorrhea drugs Lunabell (norethisterone/ethinyl estradiol) and Marvelon (desogestrel/ethinyl estradiol) respectively.